Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 51


Metabolic reprogramming: the emerging concept and associated therapeutic strategies.

Yoshida GJ.

J Exp Clin Cancer Res. 2015 Oct 6;34(1):111. doi: 10.1186/s13046-015-0221-y.


Tumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients.

Gustbée E, Tryggvadottir H, Markkula A, Simonsson M, Nodin B, Jirström K, Rose C, Ingvar C, Borgquist S, Jernström H.

BMC Clin Pathol. 2015 May 20;15:8. doi: 10.1186/s12907-015-0008-2. eCollection 2015.


Association between statin use and cancer: data mining of a spontaneous reporting database and a claims database.

Fujimoto M, Higuchi T, Hosomi K, Takada M.

Int J Med Sci. 2015 Jan 22;12(3):223-33. doi: 10.7150/ijms.10656. eCollection 2015.


Statin use and risk of pancreatic cancer: results from a large, clinic-based case-control study.

Walker EJ, Ko AH, Holly EA, Bracci PM.

Cancer. 2015 Apr 15;121(8):1287-94. doi: 10.1002/cncr.29256. Epub 2015 Feb 3.


Effects of statins on the prognosis of local and locally advanced renal cell carcinoma following nephrectomy.

Choi SK, Min GE, Jeon SH, Lee HL, Chang SG, Yoo KH.

Mol Clin Oncol. 2013 Mar;1(2):365-368. Epub 2012 Dec 24.


Statins and the risk of colorectal cancer: an updated systematic review and meta-analysis of 40 studies.

Lytras T, Nikolopoulos G, Bonovas S.

World J Gastroenterol. 2014 Feb 21;20(7):1858-70. doi: 10.3748/wjg.v20.i7.1858. Review.


Statin use is associated with reduced risk of haematological malignancies: evidence from a meta-analysis.

Yi X, Jia W, Jin Y, Zhen S.

PLoS One. 2014 Jan 31;9(1):e87019. doi: 10.1371/journal.pone.0087019. eCollection 2014.


Simvastatin inhibits glucose metabolism and legumain activity in human myotubes.

Smith R, Solberg R, Jacobsen LL, Voreland AL, Rustan AC, Thoresen GH, Johansen HT.

PLoS One. 2014 Jan 8;9(1):e85721. doi: 10.1371/journal.pone.0085721. eCollection 2014. Erratum in: PLoS One. 2014;9(3):e93202.


Can statins reduce risk of lung cancer, especially among elderly people? A meta-analysis.

Deng Z, Zhang S, Yi L, Chen S.

Chin J Cancer Res. 2013 Dec;25(6):679-88. doi: 10.3978/j.issn.1000-9604.2013.11.02.


Statin use is not associated with reduced risk of skin cancer: a meta-analysis.

Li X, Wu XB, Chen Q.

Br J Cancer. 2014 Feb 4;110(3):802-7. doi: 10.1038/bjc.2013.762. Epub 2013 Dec 24.


Endoscopic ulcers as a surrogate marker of NSAID-induced mucosal damage.

Andrew Moore R.

Arthritis Res Ther. 2013;15 Suppl 3:S4. doi: 10.1186/ar4176. Epub 2013 Jul 24. Review.


Statin use and risk of lung cancer: a meta-analysis of observational studies and randomized controlled trials.

Wang J, Li C, Tao H, Cheng Y, Han L, Li X, Hu Y.

PLoS One. 2013 Oct 25;8(10):e77950. doi: 10.1371/journal.pone.0077950. eCollection 2013.


Long-term effects of statin treatment in elderly people: extended follow-up of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER).

Lloyd SM, Stott DJ, de Craen AJ, Kearney PM, Sattar N, Perry I, Packard CJ, Briggs A, Marchbank L, Comber H, Jukema JW, Westendorp RG, Trompet S, Buckley BM, Ford I.

PLoS One. 2013 Sep 2;8(9):e72642. doi: 10.1371/journal.pone.0072642. eCollection 2013.


Prospective analysis of association between statin use and breast cancer risk in the women's health initiative.

Desai P, Chlebowski R, Cauley JA, Manson JE, Wu C, Martin LW, Jay A, Bock C, Cote M, Petrucelli N, Rosenberg CA, Peters U, Agalliu I, Budrys N, Abdul-Hussein M, Lane D, Luo J, Park HL, Thomas F, Wactawski-Wende J, Simon MS.

Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1868-76. doi: 10.1158/1055-9965.EPI-13-0562. Epub 2013 Aug 23.


Long-term follow-up of moderately hypercholesterolemic hypertensive patients following randomization to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

Margolis KL, Davis BR, Baimbridge C, Ciocon JO, Cuyjet AB, Dart RA, Einhorn PT, Ford CE, Gordon D, Hartney TJ, Julian Haywood L, Holtzman J, Mathis DE, Oparil S, Probstfield JL, Simpson LM, Stokes JD, Wiegmann TB, Williamson JD; ALLHAT Collaborative Research Group.

J Clin Hypertens (Greenwich). 2013 Aug;15(8):542-54. doi: 10.1111/jch.12139. Epub 2013 Jun 10.


Statins and the risk of lung cancer: a meta-analysis.

Tan M, Song X, Zhang G, Peng A, Li X, Li M, Liu Y, Wang C.

PLoS One. 2013;8(2):e57349. doi: 10.1371/journal.pone.0057349. Epub 2013 Feb 28.


The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.

Cholesterol Treatment Trialists' (CTT) Collaborators, Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J, Barnes EH, Voysey M, Gray A, Collins R, Baigent C.

Lancet. 2012 Aug 11;380(9841):581-90. doi: 10.1016/S0140-6736(12)60367-5. Epub 2012 May 17.


Vascular memory: can we broaden the concept of the metabolic memory?

Jermendy G.

Cardiovasc Diabetol. 2012 Apr 30;11:44. doi: 10.1186/1475-2840-11-44.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk